CPT® 3316F, Under Diagnostic/Screening Processes or Results
The Current Procedural Terminology (CPT®) code 3316F as maintained by American Medical Association, is a medical procedural code under the range - Diagnostic/Screening Processes or Results.
Subscribe to Codify by AAPC and get the code details in a flash.
Tabs
Summary
The provider assesses the presence of estrogen or progesterone receptors, cell proteins that bind to specific molecules, within tumor cells in female patients, 18 years of age or older. A tumor that is estrogen or progesterone receptor negative (ER– or PR–) does not respond to medications that interfere with the production or utilization of estrogen.
For clinical responsibility, terminology, tips and additional info
start codify free trial.
View any code changes for 2024 as well as historical information on code creation and revision.
Tabs
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.
Read a CPT® Assistant article by subscribing to Code Connect Today!
Search across Medicare Manuals, Transmittals, and more. For FREE Trial, register now!